IPOs & Raising Equity Capital

Raising equity capital is one of the most consequential decisions in corporate finance. When a firm needs funding to grow, acquire competitors, or launch new products, it must choose how to raise that capital — and at what cost. Equity financing, from early-stage venture capital rounds to a full initial public offering, involves selling ownership stakes in exchange for cash. Unlike debt financing, equity does not require scheduled repayments, but it permanently dilutes existing shareholders. Understanding the mechanics, costs, and trade-offs of raising equity capital is essential for any financial manager evaluating funding options.

What is Equity Financing?

Equity financing is the process of raising capital by selling ownership shares in a company. The buyers — whether angel investors, venture capitalists, or public market participants — receive a claim on the firm’s future earnings and assets in exchange for their investment.

The equity financing spectrum ranges from informal investments by friends and family, through structured venture capital rounds, to public offerings that raise billions. Each stage involves different investors, different levels of disclosure, and different costs. The choice between equity and debt — and the optimal mix of both — is the central question of capital structure theory.

Private Equity Financing: From Angels to Venture Capital

Before a company can access public markets, it typically passes through several rounds of private equity financing. Each round brings new investors, establishes a new valuation, and dilutes existing shareholders.

For example, if a startup has a pre-money valuation of $8 million and a venture capital firm invests $2 million, the post-money valuation is $10 million. The VC firm owns $2M / $10M = 20% of the company, and existing shareholders are diluted from 100% to 80%.

Private companies ultimately exit through one of two routes: an acquisition (another company buys them) or an IPO (they sell shares to the public for the first time). The IPO path is the most prominent form of equity issuance and the focus of the remainder of this article.

The IPO from the Issuer’s Perspective

An initial public offering is the first sale of a company’s stock to the public on a stock exchange. From the issuing firm’s perspective, the IPO is a capital-raising event with significant costs, regulatory requirements, and long-term consequences.

The typical IPO process follows six steps (per Berk, DeMarzo & Harford, Ch. 14):

1. Select an underwriter. The firm hires a lead investment bank (and often forms an underwriting syndicate) to manage the offering. In a firm commitment arrangement — the most common for large IPOs — the underwriter purchases all shares from the issuer at a negotiated price and resells them to investors, bearing the risk of unsold shares. In a best efforts arrangement, used primarily for smaller or riskier deals, the underwriter sells as many shares as possible without guaranteeing the full amount.
2. SEC registration. The company files an S-1 registration statement with the SEC, disclosing financials, business model, risk factors, and intended use of proceeds. The SEC reviews and issues comments before clearing the offering.
3. Road show. Management and the underwriters present to institutional investors (mutual funds, pension funds, hedge funds) across major financial centers over 1–2 weeks, generating interest and gauging demand.
4. Book building. Institutional investors submit non-binding indications of interest — how many shares they want and at what price. The underwriter uses this “book” to set and refine the offer price range.
5. Pricing. The final offer price is set the evening before trading begins, based on the book. The underwriter typically also receives a greenshoe (overallotment) option — the right to sell up to 15% additional shares beyond the original offering size. The syndicate typically short-sells this amount at the offering, then covers the short position either by exercising the greenshoe (if the stock rises) or by buying shares in the aftermarket (if the stock falls), providing price stabilization.
6. Allocation and trading. Shares are distributed to investors and the stock begins trading on a public exchange. The opening price is the first trade on the exchange, and the first-day close is the price at market close — both typically above the offer price due to systematic underpricing.

After listing, insiders (founders, employees, early investors) are typically subject to a lockup period of 90–180 days during which they cannot sell their shares. This contractual restriction prevents a flood of insider selling from overwhelming the limited public float.

The distinction between primary shares (newly issued by the company, with proceeds going to the firm) and secondary shares (existing shares sold by current shareholders, with proceeds going to those sellers) is critical. An IPO heavy on secondary shares signals insiders exiting rather than the company raising growth capital. For a detailed look at the IPO from the investor’s perspective — including how to evaluate an offering and the long-run performance puzzle — see our guide on Initial Public Offerings.

The Cost of Going Public

The cost of an IPO extends well beyond the headline underwriter fee. From the issuer’s perspective, three categories of costs matter:

1. The Underwriter Spread

The spread is the difference between the price the underwriter pays the issuing company and the price at which shares are sold to investors.

In the United States, the spread is remarkably consistent at approximately 7% across offerings ranging from $20 million to $80 million (Chen & Ritter, 2000). International IPO spreads average roughly 3–4%, suggesting that the U.S. market may not be fully competitive on this dimension.

2. Underpricing: Money Left on the Table

IPOs are systematically priced below their market-clearing value. The underpricing cost is the difference between what investors are willing to pay (the market price) and what the company actually receives (the offer price).

3. Other Direct Costs

Legal fees, accounting and audit costs, SEC registration fees, printing, and ongoing compliance costs (including Sarbanes-Oxley requirements for internal controls) add millions more. These costs are largely fixed, making IPOs disproportionately expensive for smaller issuers.

Equity Issuance Methods Compared

An IPO is the most prominent method of raising equity, but it is not the only one. Public companies can issue additional shares through seasoned equity offerings, and modern alternatives have emerged that bypass the traditional underwriting process.

For SEOs specifically, rights offerings deserve attention. By giving existing shareholders the first right to purchase new shares at a discount, rights offers protect shareholders from the adverse selection problem that plagues cash offers. When a firm announces a cash SEO, the market interprets it as a signal that management believes the stock is overvalued — hence the negative price reaction. Rights offers mitigate this signaling effect because existing shareholders maintain their proportional ownership.

IPO Pricing Puzzles

Decades of academic research have identified four persistent puzzles surrounding IPO pricing that directly affect the cost of raising equity capital (Berk Ch. 14.3):

1. Systematic underpricing. U.S. IPOs between 1960 and 2003 produced an average first-day return of approximately 18.3%. The winner’s curse (Rock, 1986) provides the leading explanation: uninformed investors disproportionately receive allocations in overpriced IPOs, so underpricing on average compensates them for this adverse selection. For a detailed treatment of the underpricing phenomenon and its implications for investors, see our IPO guide.

2. Hot and cold markets. IPO volume is highly cyclical. During the 2008–2009 financial crisis, issuance dropped by over 90%. During the 2020–2021 boom, record volumes were driven by low interest rates and investor enthusiasm. These swings are not fully explained by capital demand alone.

3. High issuance costs. The ~7% U.S. spread appears insensitive to deal size, and total costs (spread + underpricing + other) can exceed 20% of proceeds. International spreads are roughly half the U.S. level, raising questions about competitive dynamics among U.S. underwriters.

4. Poor long-run performance. IPO stocks purchased at the first-day close have historically underperformed the market over 3–5 year holding periods. From the issuer’s perspective, this suggests that companies may be timing their offerings to coincide with periods of market overoptimism.

For the issuing firm, these puzzles represent real costs: underpricing transfers wealth to investors, cyclical markets constrain timing, and the high all-in cost of issuance may make debt financing more attractive when leverage capacity permits.

Common Mistakes

Corporate finance professionals and investors alike make several recurring errors when analyzing equity issuance:

1. Ignoring the full cost of equity issuance. The underwriter spread (7%) is the most visible cost, but underpricing often exceeds it by a factor of two or more. Add legal fees, audit costs, SEC compliance, and ongoing public-company expenses (Sarbanes-Oxley, investor relations), and the true all-in cost of an IPO is far higher than the headline number. Compare with debt issuance costs when evaluating financing alternatives.

2. Confusing offer price with market price. The offer price is negotiated between the issuer and the underwriter. The opening price is the first trade on the exchange, and the first-day close reflects the market’s assessment of value. Retail investors cannot typically buy at the offer price — they buy at the market price, which already reflects underpricing.

3. Overlooking dilution and fully diluted share count. New equity issuance reduces existing shareholders’ ownership percentage and earnings per share. Stock options, RSUs, warrants, and convertible securities further dilute ownership. Always use the fully diluted share count — not the basic count — when calculating per-share metrics after an offering.

4. Treating SPACs as equivalent to traditional IPOs. In a de-SPAC transaction, the target company bypasses the traditional IPO book-building and roadshow process — though the SPAC itself goes through a conventional IPO with underwriters. This can result in less rigorous price discovery for the operating business. Sponsor dilution (~20% of shares) and warrant structures reduce the effective value to public shareholders, and poor average post-merger returns for SPAC investors reflect these structural disadvantages.

5. Including sunk costs in the IPO decision. Prior advisory fees, abandoned S-1 filings, and past due diligence expenses are sunk costs. They should not influence the forward-looking decision of whether to proceed with an offering. Only future incremental cash flows and costs are relevant.

Limitations of Equity Financing Analysis

1. Survivorship bias. IPO performance studies may exclude companies that were delisted or went bankrupt shortly after going public, potentially overstating average outcomes.

2. Time-varying statistics. Underpricing averages vary dramatically across decades, countries, and market conditions. The 18.3% U.S. average masks enormous variation — some years average under 10%, others exceed 60%.

3. Small-sample problems. Direct listings and auction IPOs remain relatively rare, making statistical generalizations about their costs and performance unreliable.

4. Evolving regulatory environment. The JOBS Act (2012) reduced disclosure requirements for “emerging growth companies,” SEC reforms have altered SPAC rules, and direct listing regulations continue to develop. Cost and process assumptions change with each regulatory update.

5. Firm-specific factors. The optimal equity financing strategy depends on the company’s size, growth stage, industry, existing capital structure, and market conditions. General benchmarks (7% spread, 18% underpricing) may not apply to any specific issuer.